statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years

Behind the Scenes of Regeneron Pharmaceuticals's Latest Options Trends

The Law Offices of Frank R. Cruz announces an investigation of Regeneron Pharmaceuticals, Inc. (Regeneron or the Company) (NASDAQ: REGN) on behalf of investors concerning the Companys possible...

The Law Offices of Frank R. Cruz Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors

Source: TradingView.com

 Key TakeawaysRegeneron shares were lower ahead of the opening bell Thursday morning after the DOJ filed a complaint accusing the drugmaker of manipulating Medicare's drug...

Regeneron Stock Under Microscope After DOJ Price Reporting Complaint Key Levels to Watch

News of the day for April 11, 2024

 Michael M. Santiago / Getty Images

U.S. stock futures are edging lower in premarket trading after tumbling Wednesday on the back of a hotter-than-forecast...

5 Things to Know Before the Stock Market Opens

Regulatory applications for linvoseltamab currently under review by the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA)TARRYTOWN, N.Y., April 07, 2024 (GLOBE NEWSWIRE...

Linvoseltamab Pivotal Data Presented at AACR Reinforce High Response Rate that Deepens Over Time in Patients with Heavily Pre-Treated Multiple Myeloma

DekaBank Deutsche Girozentrale lifted its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 11.9% in the fourth quarter, according to the company in its most recent...

DekaBank Deutsche Girozentrale Boosts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Moody Lynn  Lieberson LLC grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 1,592.9% during the fourth quarter, according to its most recent 13F...

Moody Lynn & Lieberson LLC Buys 4,253 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Hartford Investment Management Co. decreased its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 1.3% in the 4th quarter, Holdings Channel reports. The firm owned 7,219 shares...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Hartford Investment Management Co.

Fifth Third Bancorp reduced its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 0.7% during the fourth quarter, according to the company in its most recent disclosure with...

Fifth Third Bancorp Has $7.56 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Watchers	15,565
52-Wk Low	$684.81
52-Wk High	$998.33

Volume	116,862.00
52-Wk High	$998.33
52-Wk Low	$684.81

Period	Estimated	Reported	Surprise	Result
Q2'24	$10.58	--	--	N/A
Q1'24	$10.17	$9.55	-6.11%	MISSED
Q4'23	$10.73	$11.86	10.52%	BEAT
Q3'23	$10.68	$11.59	8.50%	BEAT
Q2'23	$9.85	$10.24	3.99%	BEAT

REGN Regeneron Pharmaceuticals, Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals